KARMMA Trademark

Trademark Overview

On Friday, November 10, 2017, a trademark application was filed for KARMMA with the United States Patent and Trademark Office. The USPTO has given the KARMMA trademark a serial number of 87679802. The federal status of this trademark filing is REGISTERED as of Tuesday, May 31, 2022. This trademark is owned by Celgene Corporation. The KARMMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and associated dermatological and immune related disorders; conducting clinical trials of pharmaceutical products for others in the field of cancer and immune related disorders; providing information about the results of clinical trials for pharmaceutical products
karmma

General Information

Serial Number87679802
Word MarkKARMMA
Filing DateFriday, November 10, 2017
Status700 - REGISTERED
Status DateTuesday, May 31, 2022
Registration Number6741839
Registration DateTuesday, May 31, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and associated dermatological and immune related disorders; conducting clinical trials of pharmaceutical products for others in the field of cancer and immune related disorders; providing information about the results of clinical trials for pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 21, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Tuesday, May 31, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 31, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 7, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 7, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, February 7, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 7, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, February 7, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 7, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 7, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 7, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 7, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, August 7, 2018SUSPENSION LETTER WRITTEN
Monday, August 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 1, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 26, 2018NON-FINAL ACTION E-MAILED
Thursday, July 26, 2018NON-FINAL ACTION WRITTEN
Thursday, July 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 3, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 25, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 25, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, April 25, 2018SUSPENSION LETTER WRITTEN
Wednesday, April 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 3, 2018ASSIGNED TO LIE
Monday, March 19, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 26, 2018NON-FINAL ACTION E-MAILED
Monday, February 26, 2018NON-FINAL ACTION WRITTEN
Friday, February 23, 2018ASSIGNED TO EXAMINER
Tuesday, November 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 14, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

karmma pharmaceutical disorders related clinical trials products cancer immune field services